Lifecore Biomedical, Inc. (LFCR) News
Track canonical SquawkNews coverage tagged to LFCR, Lifecore Biomedical, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 12 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Lifecore Biomedical to Be Acquired by Webster Equity Partners for Up to $663.7 Million
By Robb M. StewartLifecore Biomedical has agreed to be bought by Webster Equity Partners in a transaction valued at up to $663.7 million.The contract manufacturer of syringes and other injectable pharmaceutical products
NEWS | Sep 28, 2026, 01:34 PM UTC
L
Lifecore Biomedical to Be Taken Private by Webster Affiliates in $6.28-Per-Share Cash Deal Plus CVR
Lifecore Biomedical agreed to be acquired by affiliates of Webster Equity Partners in a take-private transaction that pays shareholders $6.28 in cash per share plus one contingent value right (CVR). The CVR framework inc
NEWS | Sep 28, 2026, 01:07 PM UTC
L
Lifecore Biomedical, Inc. (LFCR) To Be Acquired for $6.28/Share Cash Plus CVR
Lifecore agreed to be acquired by Webster Equity Partners for $6.28 per share in cash plus a non-tradable CVR worth up to $160M, subject to milestones. Closing is expected by end of Q4 2026, pending approvals.Material De
NEWS | Sep 28, 2026, 12:49 PM UTC
L
Lifecore Biomedical to be Acquired by Webster Equity Partners
CHASKA, Minn. and WALTHAM, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. NASDAQ:LFCR today announced that it has entered into a definitive agreement to be acquired by Webster Equity Partners in a tr
NEWS | Sep 28, 2026, 12:49 PM UTC
M
Lifecore Biomedical to be acquired by Webster Equity Partners
Lifecore Biomedical said it will be acquired by Webster Equity Partners.
MNA | Sep 28, 2026, 12:45 PM UTC
L
Lifecore Biomedical to participate at CPHI Global Conference
Lifecore Biomedical, Inc. (NASDAQ: LFCR) said it will participate at the CPHI Global Conference in 2026.
EQUITY | Sep 03, 2026, 08:07 PM UTC
L
LFCR - Lifecore Biomedical to Participate at CPHI Global Conference
LFCR - Lifecore Biomedical to Participate at CPHI Global Conference
EQUITY | Sep 03, 2026, 08:06 PM UTC
M
Lifecore Biomedical signs site-transfer agreement supporting pharma commercialization
Lifecore Biomedical (LFCR) signed an agreement for a commercial site transfer supporting a global pharmaceutical company’s tech transfer and commercial manufacturing of a currently marketed drug product.
EQUITY | Sep 02, 2026, 11:07 AM UTC
L
Lifecore Biomedical signs commercial site transfer agreement
Lifecore Biomedical (LFCR) signed an agreement for commercial site transfer supporting a global pharmaceutical company.
EQUITY | Sep 02, 2026, 11:05 AM UTC
L
Lifecore Biomedical Affirms FY2026 Sales Guidance of $120.000M-$125.000M vs $122.176M Est
Lifecore Biomedical (NASDAQ: LFCR ) affirms FY2026 sales outlook from $120.000 million-$125.000 million to $120.000 million-$125.000 million vs $122.176 million estimate.
EARNINGS | Aug 05, 2026, 11:06 AM UTC
L
LFCR - Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update - Click For R
LFCR - Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update
EARNINGS | Aug 05, 2026, 11:05 AM UTC
L
LFCR - Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
LFCR - Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
EARNINGS | Jul 29, 2026, 08:05 PM UTC